Citation Impact

Citing Papers

Zygomycetes in Human Disease
2000 Standout
Sparse network modeling and metscape-based visualization methods for the analysis of large-scale metabolomics data
2017
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Cytosine methylation regulates oviposition in the pathogenic blood fluke Schistosoma mansoni
2011 Standout
Computational mass spectrometry for small molecules
2013
Imitators of Severe Pre-eclampsia
2009
Herpes zoster ophthalmicus
1992
Navigating freely-available software tools for metabolomics analysis
2017
Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy
2020
Chronic Myelomonocytic Leukemia: Natural History and Prognostic Determinants
1989
Rheumatoid arthritis
2018 Standout
Gut microbiota functions: metabolism of nutrients and other food components
2017 Standout
The role of B cells in atherosclerosis
2018
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
2009 Standout
Fatal Gastrointestinal Mucormycosis That Invaded the Postoperative Abdominal Wall Wound in an Immunocompetent Host
1999
Elective Splenectomy in Children With Idiopathic Thrombocytopenic Purpura
2000
The changing landscape of atherosclerosis
2021 StandoutNature
Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome.
1989
Partial splenic embolization for the treatment of chronic idiopathic thrombocytopenic purpura.
1994
Predictive factors for successful laparoscopic splenectomy in immune thrombocytopenic purpura
2006
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Acute leukemia during pregnancy
2005
Chronic Idiopathic Thrombocytopenic Purpura
1994
Immune Thrombocytopenic Purpura
2002 Standout
PubChem Substance and Compound databases
2015 Standout
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
Age-related macular degeneration
2018 Standout
Metabolomics: beyond biomarkers and towards mechanisms
2016 Standout
Pre-eclampsia
2010 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
2011 Standout
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Peritoneal Mucormycosis in a Patient Receiving Continuous Ambulatory Peritoneal Dialysis
1989
Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment
2004
Chronic pure thrombocytopenia in elderly patients. An aspect of the myelodysplastic syndrome
1989
Use of chemotherapy during human pregnancy
2004
Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome
2004
Fatal Mucormycosis Presenting as an Appendiceal Mass with Metastatic Spread to the Liver during Chemotherapy-induced Granulocytopenia
1990
Risk factors and biomarkers of age-related macular degeneration
2016
Endometriosis: pathogenesis and treatment
2013 Standout
Differentiation induction therapy of myelodysplastic syndromes
1989
Herpes Zoster
2013 Standout
Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects
1992 Standout
An empirical assessment of validation practices for molecular classifiers
2011
Mining electronic health records: towards better research applications and clinical care
2012 Standout
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Robust Replication of Genotype-Phenotype Associations across Multiple Diseases in an Electronic Medical Record
2010
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
Computational Metabolomics: A Framework for the Million Metabolome
2016
Cytomegalovirus encephalitis in immunologically normal adults. Successful treatment with vidarabine.
1977
The metaRbolomics Toolbox in Bioconductor and beyond
2019
5 Myelodysplastic syndromes
1987
Mass spectral databases for LC/MS- and GC/MS-based metabolomics: State of the field and future prospects
2015
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Acute Myeloid Leukemia
2015 Standout
Zygomycetes in Human Disease
2000 Standout
Recommendations for a morphologic, immunologic, and cytogenetic (MIC) working classification of the primary and therapy-related myelodysplastic disorders
1988
Clinical pharmacology of deoxycoformycin
1981
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]
1996 Standout
Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients
1983 Standout
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Varicella-zoster virus
1996 Standout
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
1997 Standout
Therapy of Experimental Herpes Simplex Encephalitis with Aciclovir in Mice
1979
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients
1989
Romiplostim for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a single technology appraisal
2009
Cancer treatment and survivorship statistics, 2016
2016 Standout
An Italian association study and meta-analysis with previous GWAS confirm WNT4, CDKN2BAS and FN1 as the first identified susceptibility loci for endometriosis
2012
Induction of differentiation-associated changes in established human cells by infection with adeno-associated virus type 2
1992 StandoutNobel
MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis
2018 Standout
Cancer treatment and survivorship statistics, 2019
2019 Standout
In vitro susceptibility of varicella-zoster virus to acyclovir
1980 StandoutNobel
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2005 Standout
Uptake, distribution, and anabolism of acyclovir in herpes simplex virus-infected mice
1982 StandoutNobel
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications
2004
CAMERA: An Integrated Strategy for Compound Spectra Extraction and Annotation of Liquid Chromatography/Mass Spectrometry Data Sets
2011
Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases
1987
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Updates in metabolomics tools and resources: 2014–2015
2015
Treatment of Varicella–Zoster Virus Infection in Severely Immunocompromised Patients
1986
Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B
2002
Genetic and Genomic Markers of Anti-TNF Treatment Response in Rheumatoid Arthritis
2015
Analysis of the Human Adult Urinary Metabolome Variations with Age, Body Mass Index, and Gender by Implementing a Comprehensive Workflow for Univariate and OPLS Statistical Analyses
2015
MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights
2021 Standout

Works of Antonio Julià being referenced

Thrombotic thrombocytopenic purpura and pregnancy: a review of ten cases
2004
Sampling time-dependent artifacts in single-cell genomics studies
2020
Identification of a two-loci epistatic interaction associated with susceptibility to rheumatoid arthritis through reverse engineering and multifactor dimensionality reduction
2007
Pregnancy outcome in hematologic malignancies
1991
An Eight-Gene Blood Expression Profile Predicts the Response to Infliximab in Rheumatoid Arthritis
2009
Analytical Methods in Untargeted Metabolomics: State of the Art in 2015
2015
Lack of useful clinical predictors of response to splenectomy in patients with chronic idiopathic thrombocytopenic purpura
1990
Cardiovascular disease in immune-mediated inflammatory diseases
2017
Genome‐wide association study of rheumatoid arthritis in the Spanish population: KLF12 as a risk locus for rheumatoid arthritis susceptibility
2008
GWAS Replication Study Confirms the Association of PDE3A–SLCO1C1 with anti-TNF Therapy Response in Rheumatoid Arthritis
2013
Toxicity of Adenine Arabinoside in Humans
1976
Survival after intestinal mucormycosis in acute myelogenous leukemia
1986
AStream: an R package for annotating LC/MS metabolomic data
2011
Focus: A Robust Workflow for One-Dimensional NMR Spectral Analysis
2013
Myelodysplastic syndromes: a study of 101 cases according to the FAB classification
1985
Study on the Efficacy and Safety of IGIV3I Grifols (Human Intravenous Immunoglobulin) in Patients Diagnosed with Chronic Immune Thrombocytopenic Purpura.
2006
Rankless by CCL
2026